King Pharmaceuticals KG General Liability — Year 7
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearSeven.
The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's general liability — year 7.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's general liability — year 7?
- King Pharmaceuticals (KG) reported general liability — year 7 of 8.3% in Q4 2025.
- What does general liability — year 7 mean?
- Represents the total revenue or financial activity generated by the General Liability insurance segment during the seventh year of the reporting period. This data point helps investors evaluate the long-term trajectory and competitive positioning of the firm's general liability product line.